Respiratory Depression clinical trials

Explore recruiting respiratory depression clinical trials.

Recruiting respiratory depression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Depression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

L-NAC for reversal of opioid-induced respiratory depression

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A Randomized, Single-Blind, Fixed-Order Crossover Study to Assess the Effects of CSX-1004 Injection on Fentanyl-Induced Respiratory Depression in Healthy Adult Subjects and Subjects with Opioid Use Disorder

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1 Study of Fentanyl Vaccine

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Experimental hypothermia using cold ambient temperature and drug-induced inhibition of shivering in awake, healthy volunteers: a crossover, double blinded trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Respiratory Depression trials by city

Respiratory Depression in Toronto Respiratory Depression in Vancouver Respiratory Depression in Montreal Respiratory Depression in Calgary Respiratory Depression in Edmonton Respiratory Depression in Ottawa Respiratory Depression in Winnipeg Respiratory Depression in Quebec City Respiratory Depression in Hamilton Respiratory Depression in Kitchener Respiratory Depression in London Respiratory Depression in Halifax Respiratory Depression in New York Respiratory Depression in Los Angeles Respiratory Depression in Chicago Respiratory Depression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease